Reactivity | MuSpecies Glossary |
Applications | Enzyme Activity |
Format | Carrier-Free |
Details of Functionality | Measured by its ability to cleave the fluorogenic peptide substrate, Mca-RPKPVE-Nval-WRK(Dnp)-NH2 (Catalog # ES002). The specific activity is >100 pmol/min/µg, as measured under the described conditions. |
Source | Mouse myeloma cell line, NS0-derived mouse HGF Activator protein Met1-Ser653 with a C-terminal 10-His tag The pro form was purified, activated and further purified. |
Accession # | |
N-terminal Sequence | Val370 & Ile406 |
Structure / Form | Active form |
Protein/Peptide Type | Recombinant Enzymes |
Gene | Hgfac |
Purity | >95%, by SDS-PAGE under reducing conditions and visualized by silver stain |
Endotoxin Note | <1.0 EU per 1 μg of the protein by the LAL method. |
Dilutions |
|
|
Theoretical MW | 32 kDa & 28 kDa. Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors. |
|
SDS-PAGE | 35 kDa and 32 kDa, reducing conditions |
|
Publications |
|
Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
|||
Buffer | Supplied as a 0.2 μm filtered solution in Tris, NaCl and CaCl2. |
|||
Purity | >95%, by SDS-PAGE under reducing conditions and visualized by silver stain |
|||
Assay Procedure |
*Adjusted for Substrate Blank
|
Hepatocyte Growth Factor Activator (HGFA) is a serine endopeptidase that cleaves at the peptide bond between Arg494 and Val495 of single-chain human HGF precursor, generating the active heterodimer (1). HGFA is produced and secreted by the liver and normally circulates in the blood as an inactive zymogen (2, 3). The zymogen has a weak affinity for heparin but acquires a strong affinity for heparin upon activation that is linked to blood coagulation. This property may ensure the local action of this enzyme at the site of tissue injury (3). Mouse HGFA precursor (653 amino acid residues) contains several predicted domains including a signal peptide (residues 1‑29), a propeptide (residues 30‑369), and a mature and active form (residues 370 to 653) that is further processed into a short chain (residues 370‑405) and a long chain (residues 406‑653). The short chain and the long chain (catalytic domain) may form a disulfide bond linked dimer. HGFA can be activated by autocatalysis or by thrombin (4). The active protease can be inhibited by HGFA inhibitors (HAIs). Two HAIs, HAI-1 and HAI-2, are known in mouse and human. HAI-1 is not only an inhibitor, but also a specific acceptor of active HGFA, acting as a reservoir of this enzyme on the cell surface (5).
Diseases for HGF Activator (1200-SE)Discover more about diseases related to HGF Activator (1200-SE).
| Pathways for HGF Activator (1200-SE)View related products by pathway.
|
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.